AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CalciMedica, Inc. Director's Dealing 2025

Aug 19, 2025

34649_dirs_2025-08-19_59d41878-d1c7-46a4-b643-54187682dcfc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CalciMedica, Inc. (CALC)
CIK: 0001534133
Period of Report: 2025-08-15

Reporting Person: Roberts Eric W (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-15	Common Stock	P	5076	$2.8977	Acquired	54399	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	164706	Direct
Common Stock	49894	Indirect
Common Stock	10661	Indirect
Common Stock	356989	Indirect
Common Stock	66228	Indirect
Common Stock	316109	Indirect

Footnotes

F1: The weighted average purchase price for the transaction reported was $2.8977, and the range of prices were between $2.80 and $2.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.